◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › ANTHEM › Operating Income

Anthem Biosciences Limited (ANTHEM) Operating Income 2022–2026

DATA UPDATED 2026-09-20

Anthem Biosciences Limited annual operating income for fiscal 2026 was ₹7.1 billion, an increase of 19.1% from ₹5.9 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

ANTHEM Annual Operating Income

Operating Income (annual)2026-03-312025-03-312024-03-312023-03-312022-03-31
Operating Income (EBIT)₹7.1B₹5.9B₹4.2B₹3.7B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANTHEM Quarterly Operating Income

Operating Income (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-30
Operating Income (EBIT)₹1.2B₹2.3B₹1.2B₹1.8B₹1.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Operating Income at Comparable Companies

More ANTHEM metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow

All ANTHEM financial statements → Interactive ANTHEM charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.